Cargando…
The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation
BACKGROUND: Activation of the signal transducer and activator of transcription 3 (STAT3) within antigen presenting cells (APCs) is linked to abnormal APCs differentiation and function. We have previously shown that STAT3 is activated within APC by a novel contact-dependent mechanism, which plays a k...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731174/ https://www.ncbi.nlm.nih.gov/pubmed/19718269 http://dx.doi.org/10.1371/journal.pone.0006846 |
_version_ | 1782170946723905536 |
---|---|
author | Gur-Wahnon, Devorah Borovsky, Zipora Liebergall, Meir Rachmilewitz, Jacob |
author_facet | Gur-Wahnon, Devorah Borovsky, Zipora Liebergall, Meir Rachmilewitz, Jacob |
author_sort | Gur-Wahnon, Devorah |
collection | PubMed |
description | BACKGROUND: Activation of the signal transducer and activator of transcription 3 (STAT3) within antigen presenting cells (APCs) is linked to abnormal APCs differentiation and function. We have previously shown that STAT3 is activated within APC by a novel contact-dependent mechanism, which plays a key role in mediating the immunomodulatory effects of hMSC. In order to better understand the underlying mechanisms that control APC maturation in a contact dependent manner, we extended our observation to tumor cells. Tumors were shown to secrete a variety of tumor-derived factors that activate STAT3 within infiltrating APCs. We now tested whether tumor cells can activate STAT3 within APC using the contact-dependent mechanism, in addition to soluble factors, and compared these two STAT3 activating pathways. PRINCIPAL FINDINGS: We demonstrate that in addition to tumor-derived secreted factors tumor cells activate STAT3 by a mechanism that is based on cell-cell interaction. We further demonstrate that these two STAT3 activating mechanisms differ in their JAK usage and their susceptibility to JSI-124 inhibition thereby representing two distinct pathways. Significantly, although both pathways activate STAT3, they modulate DCs maturation in a different manner that results in disparate phenotypic outcomes. Whereas the soluble-dependent pathway results in an immature phenotype, the contact-dependent pathway results in an apparently mature phenotype. Albeit their mature-like phenotype these latter cells express the tolerogenic markers ILT3 and ILT4 and possess T cell inhibitory activity. SIGNIFICANCE: This data suggests that, in at least certain cellular microenvironments, cell:cell interactions represent a novel way to activate STAT3 signaling, uncouple APC activation events and consequently regulate immunity and tolerance. Significantly, we have now demonstrated that this contact-dependent signaling pathway differs from that mediated by soluble factors and cytokines, inducing disparate phenotypic outcome, suggesting these two mechanisms have different and possibly complementary biological functions. |
format | Text |
id | pubmed-2731174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-27311742009-08-31 The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation Gur-Wahnon, Devorah Borovsky, Zipora Liebergall, Meir Rachmilewitz, Jacob PLoS One Research Article BACKGROUND: Activation of the signal transducer and activator of transcription 3 (STAT3) within antigen presenting cells (APCs) is linked to abnormal APCs differentiation and function. We have previously shown that STAT3 is activated within APC by a novel contact-dependent mechanism, which plays a key role in mediating the immunomodulatory effects of hMSC. In order to better understand the underlying mechanisms that control APC maturation in a contact dependent manner, we extended our observation to tumor cells. Tumors were shown to secrete a variety of tumor-derived factors that activate STAT3 within infiltrating APCs. We now tested whether tumor cells can activate STAT3 within APC using the contact-dependent mechanism, in addition to soluble factors, and compared these two STAT3 activating pathways. PRINCIPAL FINDINGS: We demonstrate that in addition to tumor-derived secreted factors tumor cells activate STAT3 by a mechanism that is based on cell-cell interaction. We further demonstrate that these two STAT3 activating mechanisms differ in their JAK usage and their susceptibility to JSI-124 inhibition thereby representing two distinct pathways. Significantly, although both pathways activate STAT3, they modulate DCs maturation in a different manner that results in disparate phenotypic outcomes. Whereas the soluble-dependent pathway results in an immature phenotype, the contact-dependent pathway results in an apparently mature phenotype. Albeit their mature-like phenotype these latter cells express the tolerogenic markers ILT3 and ILT4 and possess T cell inhibitory activity. SIGNIFICANCE: This data suggests that, in at least certain cellular microenvironments, cell:cell interactions represent a novel way to activate STAT3 signaling, uncouple APC activation events and consequently regulate immunity and tolerance. Significantly, we have now demonstrated that this contact-dependent signaling pathway differs from that mediated by soluble factors and cytokines, inducing disparate phenotypic outcome, suggesting these two mechanisms have different and possibly complementary biological functions. Public Library of Science 2009-08-31 /pmc/articles/PMC2731174/ /pubmed/19718269 http://dx.doi.org/10.1371/journal.pone.0006846 Text en Gur-Wahnon et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gur-Wahnon, Devorah Borovsky, Zipora Liebergall, Meir Rachmilewitz, Jacob The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation |
title | The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation |
title_full | The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation |
title_fullStr | The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation |
title_full_unstemmed | The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation |
title_short | The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation |
title_sort | induction of apc with a distinct tolerogenic phenotype via contact-dependent stat3 activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731174/ https://www.ncbi.nlm.nih.gov/pubmed/19718269 http://dx.doi.org/10.1371/journal.pone.0006846 |
work_keys_str_mv | AT gurwahnondevorah theinductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT borovskyzipora theinductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT liebergallmeir theinductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT rachmilewitzjacob theinductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT gurwahnondevorah inductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT borovskyzipora inductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT liebergallmeir inductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation AT rachmilewitzjacob inductionofapcwithadistincttolerogenicphenotypeviacontactdependentstat3activation |